Vor Biopharma VOR Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Vor Biopharma’s reported figures.
Based on trailing twelve months.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's return on equity?
- Vor Biopharma (VOR) reported return on equity of -125.4% in Q1 2025.
- How has Vor Biopharma's return on equity changed year-over-year?
- Vor Biopharma's return on equity decreased by 84.3% year-over-year, from -68.1% to -125.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.